Intact Genomics presented at 4th International Conference on Natural Product Discovery and Development in the Genomic Era on Jan. 8-12, 2023

Intact Genomics had two poster presentations of our recent progresses on drug discovery R&D:
P84 – FUNGAL ARTIFICIAL CHROMOSOMES ACTIVATE THE CRYPTIC BIOSYNTHETIC GENE CLUSTER OF STROBILURINS, A POTENT AGRICULTURAL FUNGICIDE WITH HIGH COMPOUND YIELD
Chengcang Charles WU¹, Andrea Stierle², Donald Stierle², Hongyu Chen¹, Peter Korajczyk¹, Rosa Ye¹, Jeremie Ferey¹ and Niel Mondava², (1)INTACT GENOMICS, INC, ST LOUIS, MO, USA, (2)University of Montana, Missoula, MT, USA

P104 – NOVEL BIOACTIVE PRENYLATED PHENOLS DERIVED FROM HETEROLOGOUS EXPRESSION OF A PSEUDOGYMNOASCUS DESTRUCTANS SQUALENE SYNTHASE GENE IN ASPERGILLUS NIDULANS
Dr. Sung Chul Park¹, Dr. Jin Woo Bok¹, Rosa Ye², Raveena Gupta³, Matthew Robey⁴, Dr. Chengcang Charles Wu², Prof. Neil Kelleher⁴ and Prof. Nancy P. Keller¹, (1)University of Wisconsin-Madison, Madison, WI, USA, (2)INTACT GENOMICS, INC, ST LOUIS, MO, USA, (3)Northwestern University, USA, (4)Northwestern University, Evanston, IL, USA